ATH 25.0% 0.5¢ alterity therapeutics limited

short term catalysts

  1. 1,494 Posts.
    lightbulb Created with Sketch. 93
    by jaylucks on ymb:

    It is just a beginning!
    The following news will be coming soon as a logical and natural path:
    - Orphan drug designation from EMEA
    - Orphan drug designation from the rest of world.
    - Manuscript of the successful HD Phase II trial data accepted for publication in a peer-reviewed journal.
    - Partnership with a large Pharm.
    - Financial infusion from investment firms
    - NDA submission.
    - Orphan drug license granted

    PPS will shut up quickly and persistently and never come back. Less
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.5¢
Change
0.001(25.0%)
Mkt cap ! $26.19M
Open High Low Value Volume
0.5¢ 0.5¢ 0.5¢ $27.94K 6.050M

Buyers (Bids)

No. Vol. Price($)
46 57663299 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 56205001 43
View Market Depth
Last trade - 16.10pm 29/03/2024 (20 minute delay) ?
Last
0.5¢
  Change
0.001 ( 0.00 %)
Open High Low Volume
0.5¢ 0.5¢ 0.5¢ 20524121
Last updated 15.46pm 29/03/2024 ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.